ZC9-24277-88955
3 vaccinations
2 coded responses
32 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 913 / CA
- Registered
- 2021-03-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-17
Registered in v-safe
-
2021-03-17
Dose 1 — Pfizer-BioNTech
-
2021-03-17
Survey response — day 0, dose 1MedDRA: Injection site haemorrhage — Feeling: Good · Site: PainFree text: Squirting blood at injection site after administrationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-18
- 2021-03-19
- 2021-03-20
- 2021-03-21
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-31
-
2021-04-07
Dose 2 — Pfizer-BioNTech
- 2021-04-07
-
2021-04-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-09
Health check-in — days 1–6 daily, dose 2Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-10
- 2021-04-11
- 2021-04-12
-
2021-04-13
Survey response — days 1–6 daily, dose 2MedDRA: Office visit, Pregnancy, Vaginal haemorrhage — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Systemic reaction (other): Vaginal spotting/bleeding at 34 weeks pregnant · Healthcare visit (other): In office visit with OBGYN that was previously scheduledMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-13
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-14
- 2021-04-15
- 2021-04-21
- 2021-05-19
- 2021-10-06
-
2021-10-08
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-10-08
- 2021-10-09
- 2021-10-10
- 2021-10-11
- 2021-10-13
- 2021-10-14
- 2021-10-15
- 2021-10-22
- 2021-10-29
- 2021-11-05
- 2021-11-14
- 2021-11-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-17 | Pfizer-BioNTech | |
| 2 | 2021-04-07 | Pfizer-BioNTech | |
| 3 | 2021-10-08 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-13 | Unsuccessful |
Free text
Release 5 — day 0, dose 1
Systemic reaction (other): Squirting blood at injection site after administration
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Vaginal spotting/bleeding at 34 weeks pregnant
Healthcare visit (other): In office visit with OBGYN that was previously scheduled
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SRO | Injection site haemorrhage | ✓ | ✓ | ✓ |
| SRO | Pregnancy | ✓ | ✓ | ✓ |
| SRO | Vaginal haemorrhage | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release